By better understanding the underlying mechanisms and causes of such illnesses, we can produce better clinical solutions, whether diagnostic, preventative or therapeutic.
Infection and inflammation in the digestive and respiratory systems have similar underlying pathophysiological processes. By understanding this, and investing in enhancing our knowledge of these fundamental issues, we can achieve incredible things.
Respiratory diseases are major causes of death across the globe. In the UK alone, chronic obstructive pulmonary disease (COPD) kills about 25,000 people a year. Idiopathic Pulmonary Fibrosis is more common than all types of leukaemia combined. Hepatitis B and C lead to more than a million deaths each year across the globe. The range and depth of research at Nottingham, together with our partnerships with healthcare professionals, means we are well-placed to tackle these problems by better understanding their common mechanisms and processes.
With state-of-the-art infrastructure already in place, our University is perfectly positioned to expand and develop our research strengths across the field. With assets such as the Sir Peter Mansfield Imaging Centre and the FRAME Alternatives Laboratory, which aims to end the need for animal testing in science, we can move quickly to improve our cross-disciplinary collaborations and to expand our partnerships with industry.
The University of Nottingham is already home to the Nottingham Molecular Pathology Node (NMPN) which brings together research groups including the Nottingham Digestive Disease Research Unit (NDDBRU), and the Nottingham Respiratory Research Unit (NRRU), which acts as a foundation for further exploration of this vital discipline.
Research Centres, Groups and Institutes